Effect of Ligustrazine on Expression of P2X_3 Receptors in L_4/L_5 Dorsal Root Ganglion of Rats with Chronic Constriction Injury

高云,梁尚栋,穆松牛,刘征宇,姜建梅,徐昌水,张春平
DOI: https://doi.org/10.3867/j.issn.1000-3002.2008.06.003
2008-01-01
Abstract:AIM To investigate the pathway of ligustrazine to alleviate neuropathic pain induced by P2X3 receptor.METHODS Chronic constriction injury(CCI) rat model with neuropathic pain was prepared.From d 2,ligustrazine 100 mg·kg-1 was given ip once daily for 14 d.The P2X3 receptor expression in L4/L5 dorsal root ganglion(DRG) neurons was detected with immunohistochemistry assay.Whole-cell patch-clamp technique was used to measure adenosine triphospate(ATP) and α,β-methylene-ATP(α,β-meATP) activated currents in freshly isolated DRG neurons of CCI rats.RESULTS Compared with normal control,the expression of P2X3 receptors and ATP-activated currents(IATP) and α,β-meATP-activated currents(Iα,β-meATP) in L4/L5 DRG neurons did not change after ligustrazine was given to normal rats for 14 d.There was also no significant difference between sham and normal control groups.The expression of P2X3 receptor,IATP and Iα,β-meATP in L4/L5 DRG neurons of CCI model rats significantly increased compared with sham group.After ligustrazine was given ip to CCI model rats for 14 d,the expression of P2X3 receptor,IATP and Iα,β-meATP in L4/L5 DRG neurons decreased significantly.CONCLUSION Ligustrazine can alleviate neuropathic pain induced by P2X3 receptor,which may be related to its inhibitory effect on the expression of P2X3 receptor in L4/L5 DRG of CCI rats.
What problem does this paper attempt to address?